Congratulations to Dr. Nadia Khan on her position as President of Hypertension Canada!

Hypertension Canada announced Dr. Nadia Khan as the President following the 2016-2017 elections at its Annual General Meeting.

Nadia Khan, Professor of Medicine in the Division of General Internal Medicine named President of Hypertension Canada. Dr. Nadia Khan is also a scientist at the Center for Health Evaluation and Outcomes Sciences (CHEOS), and a general internist at St. Paul’s Hospital in Vancouver. Dr. Khan was elected to Hypertension Canada’s Board in 2013. Dr. Khan was a member of the Central Review Committee for the Canadian Hypertension Education Program (CHEP) from 2002 to 2013, and is Chair of Hypertension Canada’s Research Policy Committee.

In this role, Dr. Khan will continue to help build on the excellent foundation from Ernesto Schiffrin, immediate Past-President. She will continue to lead the work in early detection of high blood pressure, its treatment and overall management.

Over the past 7 years she has systematically investigated cardiovascular disease burden, acute care delivery for ACS, stroke and chronic cardiovascular disease management using multi-provincial population based datasets. This work was supported by four CIHR/HSFC operating grants and a CIHR New Investigator award.

Her overall findings have demonstrated that South Asian and Chinese are disproportionately affected by cardiovascular disease and the lifetime health burden will be greater for these populations as they have longer to live with the disease. Working with the ETHOS team, she is now systematically investigating how ethnicity impacts chronic cardiovascular disease using a multicenter cohort study of South Asian, Chinese and White patients with acute coronary syndrome. This research aims to identify specific gaps in chronic cardiovascular care and patient level barriers in these ethnic groups that are not currently known. She was recently awarded a CIHR grant for a randomized controlled trial determining the efficacy of a culturally adapted diabetes management intervention compared with usual care on diabetes and blood pressure outcomes. The long-term goal is to use this new information to inform culturally sensitive interventions to close these care gaps and improve risk factor and cardiovascular disease management of Canada’s largest ethnic populations.